SCHEMBL30788554

SCHEMBL30788554

Cc1csc(N2CCCN(Cc3cccc(Br)c3)C2=O)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.46
ADORA2A P29274 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
ADORA1 P30542 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
BRD4 O60885 1/20 0.39
BRD2 P25440 1/20 0.39
BRD3 Q15059 1/20 0.39
SCD O00767 2/20 0.38
PDE2A O00408 1/20 0.38
LMNA P02545 2/20 0.37
TSHR P16473 1/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
PKM P14618 1/20 0.37
TAS2R8 Q9NYW2 1/20 0.36
CLPP Q16740 1/20 0.36
USP2 O75604 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30788572 0.80 MAOB (0.43) MAOBADORA2AADORA1SMN1; SMN2TDP1
SCHEMBL1909503 0.79 SCD (0.55) L3MBTL1SMN1; SMN2SCDTAS2R8KMT2A
SCHEMBL30788550 0.79 SCD (0.43) MAOBADORA2AADORA1SMN1; SMN2TDP1
SCHEMBL30788640 0.74 L3MBTL1 (0.56) L3MBTL1SMN1; SMN2LMNAPKMMAPT
SCHEMBL1909686 0.73 RAB9A (0.61) L3MBTL1SMN1; SMN2SCDLMNATSHR
SCHEMBL1909621 0.71 HDAC1 (0.49) L3MBTL1SMN1; SMN2SCD
SCHEMBL240604 0.70 HDAC1 (0.53) L3MBTL1SMN1; SMN2SCDLMNATSHR
SCHEMBL244590 0.70 SCD (0.50) L3MBTL1SCDLMNA
SCHEMBL4177453 0.69 ADORA2A (0.51) MAOBADORA2AADORA1SMN1; SMN2TDP1
SCHEMBL244363 0.68 SCD (0.66) L3MBTL1SMN1; SMN2SCDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581029-A1 CYCLIC UREA THIAZOLYL COMPOUNDS FOR TREATMENT OF HSV Assembly Biosciences, Inc. (US) 2025-07-09 EP disclosed
WO-2024049760-A1 CYCLIC UREA THIAZOLYL COMPOUNDS FOR TREATMENT OF HSV ASSEMBLY BIOSCIENCES, INC. (US) 2024-03-07 WO disclosed